Safety, Tolerability, and Immunogenicity of Repeated Doses of DermaVir, a Candidate Therapeutic HIV Vaccine, in HIV-Infected Patients Receiving Combination Antiretroviral Therapy
Journal of Acquired Immune Deficiency Syndromes- United States
doi 10.1097/qai.0b013e3182a99590
Full Text
Abstract
Available in
Date
December 1, 2013
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)